Schering patents expiration
1. Noxafil patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8263600 | SCHERING | Antifungal composition with enhanced bioavailability |
Apr, 2022
(1 year, 5 months ago) | |
Drugs and Companies using POSACONAZOLE ingredient
Market Authorisation Date: 15 September, 2006
Treatment: NA
Dosage: SUSPENSION;ORAL
How can I launch a generic of NOXAFIL before it's drug patent expiration?
More Information on Dosage
NOXAFIL family patents
2. Rebetol patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6790837 | SCHERING | Ribavirin syrup formulations |
Apr, 2023
(5 months ago) | |
|
US6790837 (Pediatric) | SCHERING | Ribavirin syrup formulations |
Oct, 2023
(10 days from now) | |
Drugs and Companies using RIBAVIRIN ingredient
Market Authorisation Date: 29 July, 2003
Treatment: NA
Dosage: SOLUTION;ORAL
More Information on Dosage
REBETOL family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic